Immunization To Prevent Acute COPD Exacerbations (IMPACE Study)
Phase of Trial: Phase IV
Latest Information Update: 06 Jun 2018
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
- Acronyms IMPACE Study
- Sponsors Pfizer
- 31 Aug 2018 Biomarkers information updated
- 14 Dec 2017 Status changed from not yet recruiting to recruiting.
- 11 Oct 2017 Planned initiation date changed from 29 Sep 2017 to 27 Oct 2017.